Short-read Sequencing Market Outlook, Dynamics and Strategic Insights by 2031

MARKET OVERVIEW

A short-read sequencing instrument's read length scale is between 100 and 600 bp. Long-read sequencing is unquestionably more expensive than short-read sequencing. Short-read sequencing-based targeted DNA sequencing is utilised as a low-cost option to detect both known and unknown genetic variants in clinical research samples. Individual genes, larger genetic areas (i.e., clusters of genes or operons), full chromosomes, or entire genomes of any organism can all be sequenced using DNA sequencing.

MARKET SCOPE

The "Global Short-read Sequencing Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the short-read sequencing market with detailed market segmentation by technology, product, application, workflow and end user. The report provides key statistics on the market status of the leading short-read sequencing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on technology the market is segmented as, next-generation sequencing and sanger sequencing.
  
•   Based on product the market is segmented as, instruments, consumables and services.
  
•   Based on application the market is segmenetd as, oncology, clinical investigation, reproductive health, HLA typing/immune system monitoring, agrigenomics & forensics, consumer genomics.
  
•   Based on workflow the market is segmented as, pre-sequencing, sequencing, data analysis.
  
•   Based on end user the market is segmented as, academic research, clinical research, hospitals & clinics, pharma & biotech companies.
  

MARKET DYNAMICS

Drivers:

•   Accelerated demand for personalized medicine and companion diagnostics is expected to fuel the market growth.
  
•   Short reads are generated massively in a single run and the technology is easy to use and inexpensive which is also expected to spur the market growth.
  
•   Additionally, short read sequencing decreases the cost of genome sequencing.
  

Restraints:

•   However, high cost associated with the sequencing procedures is likely to restrain market growth during the forecast period.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The short-read sequencing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the short-read sequencing market in these regions.

IMPACT OF COVID-19 ON SHORT-READ SEQUENCING MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the short-read sequencing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from short-read sequencing market are anticipated to lucrative growth opportunities in the future with the rising demand for short-read sequencing in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the short-read sequencing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Thermo Fisher Scientific Inc.
  
•   F. Hoffmann-La Roche AG
  
•   Illumina, Inc.
  
•   Genewiz
  
•   GenScript
  
•   QIAGEN
  
•   Agilent Technologies, Inc
  
•   BGI
  
•   Fasteris SA
  
•   Cytiva
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Short-read Sequencing Report Scope